{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:27:11Z","timestamp":1791973631032,"version":"4.4.0"},"reference-count":166,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["23-15-00132"],"award-info":[{"award-number":["23-15-00132"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>During the last 100 years, vaccine development has evolved from an empirical approach to one of the more rational vaccine designs where the careful selection of antigens and adjuvants is key to the desired efficacy for challenging pathogens and\/or challenging populations. To improve immunogenicity while maintaining a favorable reactogenicity and safety profile, modern vaccine design must consider factors beyond the choice of target antigen alone. With new vaccine technologies currently emerging, it will be possible to custom-design vaccines for optimal efficacy in groups of people with different responses to vaccination. It should be noted that after a fairly long period of overwhelming dominance of papers devoted to subunit plague vaccines, materials devoted to the development of live plague vaccines have increasingly been published. In this review, we present our opinion on reasonable tactics for the development and application of live, safe, and protective human plague vaccines causing an enhanced duration of protection and breadth of action against various virulent strains in vaccination studies representing different ages, genders, and nucleotide polymorphisms of the genes responsible for immune response.<\/jats:p>","DOI":"10.3390\/vaccines13010066","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T07:40:08Z","timestamp":1736754008000},"page":"66","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Live Plague Vaccine Development: Past, Present, and Future"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-7999","authenticated-orcid":false,"given":"Andrey P.","family":"Anisimov","sequence":"first","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-3660","authenticated-orcid":false,"given":"Anastasia S.","family":"Vagaiskaya","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9223-2105","authenticated-orcid":false,"given":"Alexandra S.","family":"Trunyakova","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana V.","family":"Dentovskaya","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"ref_1","first-page":"121","article-title":"Concerning Inoculation against Plague and Pneumonia","volume":"50","author":"Haffkine","year":"1915","journal-title":"Ind. Med. Gaz."},{"key":"ref_2","first-page":"73","article-title":"Immunization against plague with live vaccine","volume":"24","author":"Otten","year":"1936","journal-title":"Indian. J. Med. Res."},{"key":"ref_3","first-page":"631","article-title":"Immunity in plague infection: Results of 30 years of work with the Pasteurella pestis EV strain (Girard and Robic)","volume":"52","author":"Girard","year":"1963","journal-title":"Biol. Med."},{"key":"ref_4","unstructured":"Korobkova, E.I. (1956). Live antiplague vaccine. Medgiz Mosc., 206."},{"key":"ref_5","first-page":"653","article-title":"Effectiveness of Live or Killed Plague Vaccines in Man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull. World Health Organ."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1078\/1438-4639-00259","article-title":"The History of the Plague and the Research on the Causative Agent Yersinia Pestis","volume":"207","author":"Zietz","year":"2004","journal-title":"Int. J. Hyg. Env. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.24171\/j.phrp.2021.0288","article-title":"Yersinia pestis Antibiotic Resistance: A Systematic Review","volume":"13","author":"Lei","year":"2022","journal-title":"PHRP"},{"key":"ref_8","unstructured":"(2018). WHO Workshop Meeting Report. Efficacy Trials of Plague Vaccines: Endpoints, Trial Design, Site Selection, INSERM. Available online: https:\/\/www.who.int\/publications\/m\/item\/efficacy-trials-of-plague-vaccines--endpoints--trial-design--site-selection-who-workshop."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-3387-7_3","article-title":"Principles of Vaccination","volume":"Volume 1403","author":"Thomas","year":"2016","journal-title":"Vaccine Design"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current Challenges in the Development of Vaccines for Pneumonic Plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for New Plague Vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4161\/hv.9866","article-title":"Plague Vaccines and the Molecular Basis of Immunity against Yersinia Pestis","volume":"5","author":"Quenee","year":"2009","journal-title":"Hum. Vaccines"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia Pestis (Plague) Vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune Defense against Pneumonic Plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3855\/jidc.2030","article-title":"Developing Live Vaccines against Plague","volume":"5","author":"Sun","year":"2011","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41541-024-00958-1","article-title":"Progress on the Research and Development of Plague Vaccines with a Call to Action","volume":"9","author":"Williamson","year":"2024","journal-title":"Npj Vaccines"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2174\/1389201014666131226122243","article-title":"Rational Considerations about Development of Live Attenuated Yersinia pestis Vaccines","volume":"14","author":"Sun","year":"2014","journal-title":"CPB"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/infdis\/73.2.124","article-title":"Avirulent Strains of Pasteurella Pestis","volume":"73","author":"Jawetz","year":"1943","journal-title":"J. Infect. Dis."},{"key":"ref_19","first-page":"165","article-title":"Plague Studies. III. Problems in Immunology","volume":"5","author":"Pollitzer","year":"1952","journal-title":"Bull. World Health Organ."},{"key":"ref_20","first-page":"673","article-title":"De l\u2019attenuation du virus du cholera des poules","volume":"91","author":"Pasteur","year":"1880","journal-title":"CR Acad. Sci. Paris"},{"key":"ref_21","first-page":"457","article-title":"Nouvelle com-municationsur la rage","volume":"98","author":"Pasteur","year":"1884","journal-title":"CR Acad. Sci. Paris"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.82","article-title":"Russian Vaccines against Especially Dangerous Bacterial Pathogens","volume":"3","author":"Feodorova","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e01722-20","DOI":"10.1128\/JVI.01722-20","article-title":"Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins","volume":"95","author":"Ghorbani","year":"2020","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live Attenuated Vaccines: Historical Successes and Current Challenges","volume":"479\u2013480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3389\/fphar.2020.01050","article-title":"BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?","volume":"11","author":"Kamat","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.20506\/rst.37.2.2831","article-title":"New Developments in Rabies Vaccination: -EN- New Developments in Rabies Vaccination -FR- Les D\u00e9veloppements R\u00e9cents Dans Le Domaine de La Vaccination Antirabique -ES- Novedades En Materia de Vacunaci\u00f3n Antirr\u00e1bica","volume":"37","author":"Fisher","year":"2018","journal-title":"Rev. Sci. Tech. OIE"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.micinf.2018.01.005","article-title":"Measles-Derived Vaccines to Prevent Emerging Viral Diseases","volume":"20","author":"Frantz","year":"2018","journal-title":"Microbes Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/IAI.01507-05","article-title":"Attenuation and Persistence of and Ability to Induce Protective Immunity to a Staphylococcus Aureus aroA Mutant in Mice","volume":"74","author":"Buzzola","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From Brain Passage to Cell Adaptation: The Road of Human Rabies Vaccine Development","volume":"10","author":"Wu","year":"2011","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7883\/yoken.JJID.2007.331","article-title":"Historical Review of BCG Vaccine in Japan","volume":"60","author":"Yamamoto","year":"2007","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.65.6.767","article-title":"The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus","volume":"65","author":"Theiler","year":"1937","journal-title":"J. Exp. Med."},{"key":"ref_32","first-page":"16","article-title":"Experimental Appraisal of Antiplague Vaccination with Dead Virulent and Living Avirulent Plague Bacilli","volume":"56","author":"Meyer","year":"1948","journal-title":"Abstr. Int. Congr. Trop. Med. Malar."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0028-1138568","article-title":"Die aktive Immunisirung gegen Pest mittelst abgeschw\u00e4chter Kulturen","volume":"29","author":"Kolle","year":"1903","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/infdis\/96.2.145","article-title":"Studies on Immunization Against Plague XI. A Study of the Immunogenicity and Toxicity of Eleven Avirulent Variants of Virulent Strains of Pasteurella Pestis","volume":"96","author":"Chen","year":"1955","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3103\/S0891416819020058","article-title":"Rational Taxonomy of Yersinia pestis","volume":"34","author":"Kislichkina","year":"2019","journal-title":"Mol. Genet. Microbiol. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.4161\/hv.35119","article-title":"Comparison of Virulence between the Yersinia Pestis Microtus 201, an Avirulent Strain to Humans, and the Vaccine Strain EV in Rhesus Macaques, Macaca Mulatta","volume":"10","author":"Tian","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_37","unstructured":"Feodorova, V.A., and Motin, V.L. (2011). Plague vaccines. Vaccines Against Bacterial Biothreat Pathogens, Research Signpost."},{"key":"ref_38","first-page":"278","article-title":"The Effects of Loss of Different Virulence Determinants on the Virulence and Immunogenicity of Strains of Pasteurella Pestis","volume":"39","author":"Burrows","year":"1958","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lindler, L.E., Lebeda, F.J., and Korch, G.W. (2005). Genetic Fingerprinting of Biodefense Pathogens for Epidemiology and Forensic Investigation. Biological Weapons Defense, Humana Press.","DOI":"10.1385\/1592597645"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21055\/0370-1069-2013-3-63-69","article-title":"Historical and Modern Views on the Problem of Specific Plague Prophylaxis","volume":"3","author":"Bugorkova","year":"2013","journal-title":"Probl. Osob. Opasnykh Infektsii"},{"key":"ref_41","first-page":"110","article-title":"K istorii razvitiia profilaktiki chumy v SSSR [History of the development of plague prevention in the USSR]","volume":"4","author":"Nikolaev","year":"1979","journal-title":"Zh Mikrobiol. Epidemiol. Immunobiol."},{"key":"ref_42","first-page":"293","article-title":"Studies in B. pestis Antigens: III. The Prophylactic Value of the Envelope and Somatic Antigens of B. pestis","volume":"13","year":"1932","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_43","first-page":"284","article-title":"Studies in B. pestis Antigens: I. The antigens and immunity reactions of B. pestis","volume":"13","year":"1932","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_44","first-page":"235","article-title":"Studies on B. pestis antigens as prophylactic agents","volume":"20","year":"1939","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0014-5793(90)80852-A","article-title":"Nucleotide Sequence of the Yersinia Pestis Gene Encoding F1 Antigen and the Primary Structure of the Protein: Putative T and B Cell Epitopes","volume":"277","author":"Galyov","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/CMR.17.2.434-464.2004","article-title":"Intraspecific Diversity of Yersinia Pestis","volume":"17","author":"Anisimov","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-642-65297-4_4","article-title":"The Genus Yersinia: Biochemistry and Genetics of Virulence With 3 Figures","volume":"Volume 18","author":"White","year":"1972","journal-title":"Modern Aspects of Electrochemistry"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Henle, W., Kikuth, W., Meyer, K.F., Nauck, E.G., and Tomcsik, J. (1963). Virulence of Pasteurella pestis and immunity to plague. Ergebnisse der Mikrobiologie Immunit\u00e4tsforschung und Experimentellen Therapie, Springer.","DOI":"10.1007\/978-3-662-36742-1"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0140-6736(58)90925-5","article-title":"A non-toxic complex from Pasteurella pestis which immunises both guineapigs and mice","volume":"271","author":"Keppie","year":"1958","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Byvalov, A.A., Konyshev, I.V., Uversky, V.N., Dentovskaya, S.V., and Anisimov, A.P. (2020). Yersinia Outer Membrane Vesicles as Potential Vaccine Candidates in Protecting against Plague. Biomolecules, 10.","DOI":"10.3390\/biom10121694"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/177426b0","article-title":"An Antigen Determining Virulence in Pasteurella Pestis","volume":"177","author":"Burrows","year":"1956","journal-title":"Nature"},{"key":"ref_52","first-page":"481","article-title":"The Basis of Virulence in Pasteurella Pestis: An Antigen Determining Virulence","volume":"37","author":"Bacon","year":"1956","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-4939-3387-7_27","article-title":"Assessment of Live Plague Vaccine Candidates","volume":"Volume 1403","author":"Thomas","year":"2016","journal-title":"Vaccine Design"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fcimb.2017.00448","article-title":"Identification of New Virulence Factors and Vaccine Candidates for Yersinia Pestis","volume":"7","author":"Andersson","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Cote, C.K., Biryukov, S.S., Klimko, C.P., Shoe, J.L., Hunter, M., Rosario-Acevedo, R., Fetterer, D.P., Moody, K.L., Meyer, J.R., and Rill, N.O. (2021). Protection Elicited by Attenuated Live Yersinia Pestis Vaccine Strains against Lethal Infection with Virulent Y. Pestis. Vaccines, 9.","DOI":"10.3390\/vaccines9020161"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41435-019-0065-0","article-title":"Yersinia Pestis and Plague: An Updated View on Evolution, Virulence Determinants, Immune Subversion, Vaccination, and Diagnostics","volume":"20","author":"Demeure","year":"2019","journal-title":"Genes. Immun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1128\/CVI.00499-15","article-title":"Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia Pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity to Completely Protect Animals against Pneumonic Plague","volume":"22","author":"Tiner","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1038\/npjvaccines.2016.20","article-title":"Immunisation of Two Rodent Species with New Live-Attenuated Mutants of Yersinia Pestis CO92 Induces Protective Long-Term Humoral- and Cell-Mediated Immunity against Pneumonic Plague","volume":"1","author":"Tiner","year":"2016","journal-title":"Npj Vaccines"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/IAI.00976-09","article-title":"The smpB-ssrA Mutant of Yersinia Pestis Functions as a Live Attenuated Vaccine to Protect Mice against Pulmonary Plague Infection","volume":"78","author":"Okan","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/IAI.72.2.908-915.2004","article-title":"Generation of Yersinia Pestis Attenuated Strains by Signature-Tagged Mutagenesis in Search of Novel Vaccine Candidates","volume":"72","author":"Flashner","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/IAI.02913-14","article-title":"High-Throughput, Signature-Tagged Mutagenic Approach to Identify Novel Virulence Factors of Yersinia Pestis CO92 in a Mouse Model of Infection","volume":"83","author":"Ponnusamy","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1128\/IAI.69.12.7810-7819.2001","article-title":"Application of High-Density Array-Based Signature-Tagged Mutagenesis to Discover Novel Yersinia Virulence-Associated Genes","volume":"69","author":"Karlyshev","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jprot.2011.10.004","article-title":"A Proteome Reference Map and Virulence Factors Analysis of Yersinia Pestis 91001","volume":"75","author":"Zhou","year":"2012","journal-title":"J. Proteom."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2144\/01302pf02","article-title":"Detection and Identification of Virulence Factors in Yersinia Pestis Using SELDI ProteinChip\u00ae System","volume":"30","author":"Thulasiraman","year":"2001","journal-title":"BioTechniques"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cbpa.2008.01.023","article-title":"Discovery of Virulence Factors of Pathogenic Bacteria","volume":"12","author":"Wu","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-3083.2008.02107.x","article-title":"Developing Antibacterial Vaccines in Genomics and Proteomics Era","volume":"67","author":"Kaushik","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1093\/cid\/10.Supplement_2.S274","article-title":"Molecular Koch\u2019s postulates applied to microbial pathogenicity","volume":"2","author":"Falkow","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-94-024-0890-4_12","article-title":"Plague Vaccines: Status and Future","volume":"Volume 918","author":"Yang","year":"2016","journal-title":"Yersinia Pestis: Retrospective and Perspective"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA Vaccine Producing LcrV Antigen in Oligomers Is Effective in Protecting Mice from Lethal Mucosal Challenge of Plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1247041","DOI":"10.3389\/fmicb.2023.1247041","article-title":"A Self-Amplifying RNA Vaccine Provides Protection in a Murine Model of Bubonic Plague","volume":"14","author":"Shattock","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.vaccine.2016.09.063","article-title":"Intranasal Delivery of a Protein Subunit Vaccine Using a Tobacco Mosaic Virus Platform Protects against Pneumonic Plague","volume":"34","author":"Arnaboldi","year":"2016","journal-title":"Vaccine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cimid.2012.10.005","article-title":"Characterization of Systemic and Pneumonic Murine Models of Plague Infection Using a Conditionally Virulent Strain","volume":"36","author":"Ramirez","year":"2013","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.vaccine.2005.12.057","article-title":"Plant-Made Subunit Vaccine against Pneumonic and Bubonic Plague Is Orally Immunogenic in Mice","volume":"24","author":"Alvarez","year":"2006","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e00081-20","DOI":"10.1128\/IAI.00081-20","article-title":"Induction of Protective Antiplague Immune Responses by Self-Adjuvanting Bionanoparticles Derived from Engineered Yersinia Pestis","volume":"88","author":"Wang","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and Systemic Immune Response to a Microencapsulated Sub-Unit Vaccine for Plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"key":"ref_76","unstructured":"(2025, January 10). Marketing Authorization from the State Research Centre for Applied Microbiology and Biotechnology of the Federal Service for the Supervision of Consumer Rights and Protection (Russia); Registration LP-004808 Microencapsulated Molecular Plague Vaccine (PMMM, 2024). Available online: https:\/\/www.rlsnet.ru\/regdoc\/vakcinacumnaya-molekulyarnaya-mikroinkapsulirovannaya-vcmm-lp-004808-74621."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cid, R., and Bol\u00edvar, J. (2021). Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules, 11.","DOI":"10.3390\/biom11081072"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/0-306-48416-1_87","article-title":"Susceptibility to Plague of the Rodents in Antananarivo, Madagascar","volume":"Volume 529","author":"Skurnik","year":"2004","journal-title":"The Genus Yersinia"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/infdis\/7.3.374","article-title":"The Susceptibility to Plague of the Prairie Dog, the Desert Wood Rat, and the Rock Squirrel","volume":"7","author":"McCoy","year":"1910","journal-title":"J. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1002\/ece3.5684","article-title":"Differential Plague Susceptibility in Species and Populations of Prairie Dogs","volume":"9","author":"Russell","year":"2019","journal-title":"Ecol. Evol."},{"key":"ref_81","first-page":"720","article-title":"Susceptibility and Non-Susceptibility to Plague of Some Animals","volume":"7","author":"Uriarte","year":"1936","journal-title":"Rev. Inst. Bacteriolog."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/infdis\/129.Supplement_1.S85","article-title":"Live, Attenuated Yersinia Pestis Vaccine: Virulent in Nonhuman Primates, Harmless to Guinea Pigs","volume":"129","author":"Meyer","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"20240724","DOI":"10.1098\/rspb.2024.0724","article-title":"Differential Pathogenicity and Lethality of Bubonic Plague (1720\u20131945) by Sex, Age and Place","volume":"291","author":"Mongillo","year":"2024","journal-title":"Proc. R. Soc. B"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1093\/infdis\/129.Supplement_1.S53","article-title":"Comparison of the Immune Response to Three Different Yersinia Pestis Vaccines in Guinea Pigs and Langurs","volume":"129","author":"Chen","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrg3114","article-title":"Human Genetic Susceptibility to Infectious Disease","volume":"13","author":"Chapman","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"eaal5068","DOI":"10.1126\/sciimmunol.aal5068","article-title":"Helicobacter Species Are Potent Drivers of Colonic T Cell Responses in Homeostasis and Inflammation","volume":"2","author":"Chai","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/annrheumdis-2020-216936","article-title":"Of Mice, Men and Microbes: The Impact of the Microbiome on Immune Responses","volume":"79","author":"Pisetsky","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"867015","DOI":"10.3389\/fimmu.2022.867015","article-title":"A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates","volume":"13","author":"Fragiadakis","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How Sex and Age Affect Immune Responses, Susceptibility to Infections, and Response to Vaccination","volume":"14","author":"Berger","year":"2015","journal-title":"Aging Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1397579","DOI":"10.3389\/fimmu.2024.1397579","article-title":"Sex Differences in Immune Protection in Mice Conferred by Heterologous Vaccines for Pneumonic Plague","volume":"15","author":"Davies","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.meegid.2009.10.003","article-title":"Amino Acid and Structural Variability of Yersinia Pestis LcrV Protein","volume":"10","author":"Anisimov","year":"2010","journal-title":"Infect. Genet. Evol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e0162308","DOI":"10.1371\/journal.pone.0162308","article-title":"Yersinia Pestis Caf1 Protein: Effect of Sequence Polymorphism on Intrinsic Disorder Propensity, Serological Cross-Reactivity and Cross-Protectivity of Isoforms","volume":"11","author":"Kopylov","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0882-4010(91)90005-U","article-title":"Integration of the Plasmid Encoding the Synthesis of Capsular Antigen and Murine Toxin into Yersinia Pestis Chromosome","volume":"11","author":"Protsenko","year":"1991","journal-title":"Microb. Pathog."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.01162-08","article-title":"Yersinia Pestis IS 1541 Transposition Provides for Escape from Plague Immunity","volume":"77","author":"Cornelius","year":"2009","journal-title":"Infect Immun"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/IAI.00105-08","article-title":"Yersinia Pestis Caf1 Variants and the Limits of Plague Vaccine Protection","volume":"76","author":"Quenee","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00253-011-3380-6","article-title":"Progress on Plague Vaccine Development","volume":"91","author":"Rosenzweig","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/emi.2012.34","article-title":"Plague Vaccines: Current Developments and Future Perspectives","volume":"1","author":"Feodorova","year":"2012","journal-title":"Emerg. Microbes Infect."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) Vaccine Protects Cynomolgus Macaques against Pneumonic Plague","volume":"29","author":"Williamson","year":"2011","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.1100174","article-title":"Yersinia Pestis YopE Contains a Dominant CD8 T Cell Epitope That Confers Protection in a Mouse Model of Pneumonic Plague","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/IAI.01595-13","article-title":"Deletion of Braun Lipoprotein and Plasminogen-Activating Protease-Encoding Genes Attenuates Yersinia Pestis in Mouse Models of Bubonic and Pneumonic Plague","volume":"82","author":"Sha","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/IAI.02778-14","article-title":"Combinational Deletion of Three Membrane Protein-Encoding Genes Highly Attenuates Yersinia Pestis While Retaining Immunogenicity in a Mouse Model of Pneumonic Plague","volume":"83","author":"Tiner","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V Antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/JCM.00064-11","article-title":"Characterization of an F1 Deletion Mutant of Yersinia Pestis CO92, Pathogenic Role of F1 Antigen in Bubonic and Pneumonic Plague, and Evaluation of Sensitivity and Specificity of F1 Antigen Capture-Based Dipsticks","volume":"49","author":"Sha","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fimmu.2016.00602","article-title":"Plague Vaccine Development: Current Research and Future Trends","volume":"7","author":"Verma","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-019-0105-9","article-title":"Plague Vaccine: Recent Progress and Prospects","volume":"4","author":"Sun","year":"2019","journal-title":"Npj Vaccines"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s00253-021-11389-6","article-title":"Plague Vaccines: New Developments in an Ongoing Search","volume":"105","author":"Rosenzweig","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/erv.13.42","article-title":"Live-Attenuated Yersinia Pestis Vaccines","volume":"12","author":"Wang","year":"2013","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21055\/0370-1069-2019-1-50-63","article-title":"Current State of the Problem of Vaccine Development for Specific Prophylaxis of Plague","volume":"1","author":"Mikshis","year":"2019","journal-title":"Probl. Osob. Opasnykh Infektsii"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21055\/0370-1069-2018-2-6-13","article-title":"Scientific and Methodological Support of Activities on Carrying Out Immunological Monitoring of Vaccinated Against Plague Persons Residing in the Territories of Natural Foci of the Infection","volume":"2","author":"Bugorkova","year":"2018","journal-title":"Probl. Osob. Opasnykh Infektsii"},{"key":"ref_111","first-page":"482","article-title":"Investigations on the epidemiology and control of plague in South Vietnam. Part I","volume":"4","author":"Velimirovic","year":"1974","journal-title":"Zentralblatt F\u00fcr Bakteriol. Orig."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/CVI.00386-10","article-title":"Serum Cytokine Responses in Primary Pneumonic Plague Patients","volume":"18","author":"Wang","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0035-9203(46)90069-7","article-title":"Control of Plague by Means of Live Avirulent Plague Vaccine in Southern Africa (1941\u20131944)","volume":"40","author":"Grasset","year":"1946","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_114","first-page":"373","article-title":"Live plague vaccine as a prophylactic against plague","volume":"15","author":"Grasset","year":"1941","journal-title":"South. Afr. Med. J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e0218366","DOI":"10.1371\/journal.pone.0218366","article-title":"Human Response to Live Plague Vaccine EV, Almaty Region, Kazakhstan, 2014\u20132015","volume":"14","author":"Sagiyev","year":"2019","journal-title":"PLoS ONE"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"100072","DOI":"10.1016\/j.crimmu.2023.100072","article-title":"The Efficacy, Safety, and Immunogenicity of Plague Vaccines: A Systematic Literature Review","volume":"4","author":"Hartley","year":"2023","journal-title":"Curr. Res. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0022-3859.173187","article-title":"The Clinical Development Process for a Novel Preventive Vaccine: An Overview","volume":"62","author":"Singh","year":"2016","journal-title":"J. Postgrad. Med."},{"key":"ref_118","unstructured":"World Health Organization (2004). Guidelines on clinical evaluation of vaccines: Regulatory expectations. WHO Tech. Rep. Ser., 1004, 72."},{"key":"ref_119","unstructured":"Anisimova, T.I., Sayapina, L.V., Sergeeva, G.M., Isupov, I.V., Beloborodov, R.A., Samoilova, L.V., Anisimov, A.P., Ledvanov, M.Y., Shvedun, G.P., and Zadumina, S.Y. (2002). [Main Requirements for Vaccine Strains of the Plague Pathogen: Methodological Guidelines MU 3.3.1.1113-02], Federal Centre of State Epidemic Surveillance of Ministry of Health of Russian Federation."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2007.10.032","article-title":"Molecular Characterization of L-413C, a P2-Related Plague Diagnostic Bacteriophage","volume":"372","author":"Garcia","year":"2008","journal-title":"Virology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia Pestis--Etiologic Agent of Plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0882-4010(87)90051-9","article-title":"Modulation of the Low-Calcium Response in Yersinia Pestis via Plasmid-Plasmid Interaction","volume":"2","author":"Sample","year":"1987","journal-title":"Microb. Pathog."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Sebbane, F., Uversky, V.N., and Anisimov, A.P. (2020). Yersinia Pestis Plasminogen Activator. Biomolecules, 10.","DOI":"10.3390\/biom10111554"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/j.1365-2958.1992.tb01446.x","article-title":"Loss of the Pigmentation Phenotype in Yersinia Pestis Is Due to the Spontaneous Deletion of 102 Kb of Chromosomal DNA Which Is Flanked by a Repetitive Element","volume":"6","author":"Fetherston","year":"1992","journal-title":"Mol. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1134\/S0006297911070121","article-title":"Functional Characterization and Biological Significance of Yersinia Pestis Lipopolysaccharide Biosynthesis Genes","volume":"76","author":"Dentovskaya","year":"2011","journal-title":"Biochem. Mosc."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e25486","DOI":"10.1371\/journal.pone.0025486","article-title":"Bacteriophage-Resistant Mutants in Yersinia Pestis: Identification of Phage Receptors and Attenuation for Mice","volume":"6","author":"Filippov","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"102","DOI":"10.32607\/20758251-2015-7-1-102-108","article-title":"Selective protective potency of Yersinia pestis \u0394nlpD mutants","volume":"7","author":"Dentovskaya","year":"2015","journal-title":"Acta Nat."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fcimb.2020.00473","article-title":"Construction of a Live-Attenuated Vaccine Strain of Yersinia Pestis EV76-B-SHU\u0394pla and Evaluation of Its Protection Efficacy in a Mouse Model by Aerosolized Intratracheal Inoculation","volume":"10","author":"Feng","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/IAI.73.6.3734-3739.2005","article-title":"Protein Microarray for Profiling Antibody Responses to Yersinia Pestis Live Vaccine","volume":"73","author":"Li","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/978-0-387-72124-8_35","article-title":"Cell-Mediated Defense Against Yersinia Pestis Infection","volume":"Volume 603","author":"Perry","year":"2007","journal-title":"The Genus Yersinia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4161\/hv.27060","article-title":"Yersinia Pestis Biovar Microtus Strain 201, an Avirulent Strain to Humans, Provides Protection against Bubonic Plague in Rhesus Macaques","volume":"10","author":"Zhang","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"373","DOI":"10.15789\/2220-7619-2015-4-373-376","article-title":"Selection of phylogenetically closely-related Yersinia pestis strains differing in their virulence for guinea pigs","volume":"5","author":"Anisimov","year":"2016","journal-title":"Russ. J. Infect. Immun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S0025727300028003","article-title":"A History of Medicine, vol. II: Early Greek, Hindu, and Persian Medicine by Henry F. Sigerist, London, Oxford University Press, 1961, pp. 333, 75s","volume":"7","author":"Cawadias","year":"1963","journal-title":"Med. Hist."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0160-8002(79)90022-4","article-title":"Illness and Health Practitione Use in Calabar, Nigeria","volume":"13","author":"Gesler","year":"1979","journal-title":"Soc. Sci. Medicine. Part. D Med. Geogr."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1017\/S0022172400006148","article-title":"Concerning Inoculation against Plague and Pneumonia and the Experimental Study of Curative Methods","volume":"15","author":"Haffkine","year":"1915","journal-title":"J. Hyg."},{"key":"ref_136","first-page":"559","article-title":"Essays of the History of Plague: In 2 Volumes. Moscow: Vuzovskaya Kniga, 2006. (Volume 1: Plague of Pre-Bacteriological Period. 468 P. ISBN 5-9502-0093-4; Volume 2: Plague of Bacteriological Period. 696 p. ISBN 5-9502-0094-2.)","volume":"5","author":"Supotnitsky","year":"2010","journal-title":"JSPS"},{"key":"ref_137","first-page":"19","article-title":"Genetic Markers of Immune Response to Yersinia pestis F1 and V Antigens\u2013Loaded Microspheres Vaccine Against Plague","volume":"2","author":"Nazarova","year":"2017","journal-title":"Russ. Biomed. Res."},{"key":"ref_138","first-page":"3","article-title":"[Experience from a 30-year study of the stability of the properties of the plague vaccine strain EV in the USSR]","volume":"6","author":"Saltykova","year":"1975","journal-title":"Zh Mikrobiol. Epidemiol. Immunobiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.meegid.2014.05.023","article-title":"Genetic Variations of Live Attenuated Plague Vaccine Strains (Yersinia Pestis EV76 Lineage) during Laboratory Passages in Different Countries","volume":"26","author":"Cui","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.23950\/1812-2892-2016-1-25-29","article-title":"The \u201canimalization\u201d influence on the specific activity of a live plague vaccine in the model animal experiments","volume":"1","author":"Ponomareva","year":"2016","journal-title":"J. Clin. Med. Kaz."},{"key":"ref_141","unstructured":"Teterin, V.V., Ezhov, A.V., Birjukov, V.V., Mokhov, D.A., Bagin, S.V., Khonin, A.Z., and Logvinov, S.V. (2014). Method of Obtaining Preparation Based on Vaccine Strain of Plague Microbe. (2510825 C2), RU Patent, Available online: https:\/\/www.elibrary.ru\/item.asp?id=37796412."},{"key":"ref_142","unstructured":"Khesin, R.B. (1985). Genome Inconstancy, Nauka."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/mmi.14655","article-title":"RecA-independent Recombination: Dependence on the Escherichia Coli RarA Protein","volume":"115","author":"Jain","year":"2021","journal-title":"Mol. Microbiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10409230701260258","article-title":"Regulation of Bacterial RecA Protein Function","volume":"42","author":"Cox","year":"2007","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm2099","article-title":"Motoring along with the Bacterial RecA Protein","volume":"8","author":"Cox","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1016\/S0264-410X(03)00434-1","article-title":"A recA Deletion Mutant of Mycobacterium Bovis BCG Confers Protection Equivalent to That of Wild-Type BCG but Shows Increased Genetic Stability","volume":"21","author":"Sander","year":"2003","journal-title":"Vaccine"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3103\/S0891416815030039","article-title":"Construction and Characterization of Francisella Tularensis Vaccine Strain with a Single Copy of iglC Gene and Lacking recA Gene","volume":"30","author":"Mokrievich","year":"2015","journal-title":"Mol. Genet. Microbiol. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1240698","DOI":"10.3389\/fbrio.2023.1240698","article-title":"Live Attenuated Vaccines and Layered Defense Strategies to Combat Infections Caused by Nonencapsulated Yersinia Pestis","volume":"2","author":"Biryukov","year":"2023","journal-title":"Front. Bacteriol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/pai.12102","article-title":"Allergic Reactions to Vaccines","volume":"24","author":"Wood","year":"2013","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3103\/S089141681303004X","article-title":"Molecular Bases of Vaccine-Prevention of Plague","volume":"28","author":"Dentovskaya","year":"2013","journal-title":"Mol. Genet. Microbiol. Virol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"400","DOI":"10.18176\/jiaci.0562","article-title":"Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review","volume":"30","author":"Caballero","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"531","DOI":"10.15789\/1563-0625-2014-6-531-538","article-title":"Influence of CpG ODN 2006 oligodeoxynucleotide on cytokine production by blood cells of humans vaccinated against plague","volume":"16","author":"Klyueva","year":"2015","journal-title":"Med. Imm. Rus"},{"key":"ref_153","first-page":"97","article-title":"Proteins of the Plague Microbe Vaccine Strain (Yersinia Pestis EV NIIEG) with Potential Allergen Properties","volume":"4","author":"Sutyagin","year":"2019","journal-title":"Probl. Osob. Opasnykh Infektsii"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Pollitzer, R. (1961). Observations on the Present State of Plague and Plague Control in the Soviet Union (According to Data Available to 31 October 1960). III. (DA 18-108-405-CML-867). ICRS Med. Rep., 1\u201349.","DOI":"10.21236\/AD0259286"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e03223-21","DOI":"10.1128\/mBio.03223-21","article-title":"Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague","volume":"12","author":"Kilgore","year":"2021","journal-title":"mBio"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e7023","DOI":"10.1371\/journal.pone.0007023","article-title":"The NlpD Lipoprotein Is a Novel Yersinia Pestis Virulence Factor Essential for the Development of Plague","volume":"4","author":"Tidhar","year":"2009","journal-title":"PLoS ONE"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"59","DOI":"10.21055\/0370-1069-2024-1-59-66","article-title":"Bacterial Vaccines with Regulated Delayed Attenuation","volume":"1","author":"Platonov","year":"2024","journal-title":"Probl. Osob. Opasnykh Infektsii"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/IAI.00693-08","article-title":"Salmonella Enterica Serovar Typhimurium Strains with Regulated Delayed Attenuation In Vivo","volume":"77","author":"Curtiss","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.7150\/thno.33046","article-title":"Regulated Delayed Shigella Flexneri 2a O-Antigen Synthesis in Live Recombinant Salmonella Enterica Serovar Typhimurium Induces Comparable Levels of Protective Immune Responses with Constitutive Antigen Synthesis System","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/IAI.01122-09","article-title":"Yersinia Pestis with Regulated Delayed Attenuation as a Vaccine Candidate to Induce Protective Immunity against Plague","volume":"78","author":"Sun","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1073\/pnas.0803801105","article-title":"Regulated Programmed Lysis of Recombinant Salmonella in Host Tissues to Release Protective Antigens and Confer Biological Containment","volume":"105","author":"Kong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/IAI.05526-11","article-title":"Live Attenuated Salmonella Vaccines Displaying Regulated Delayed Lysis and Delayed Antigen Synthesis to Confer Protection against Mycobacterium Tuberculosis","volume":"80","author":"Yang","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1016\/j.vaccine.2015.07.063","article-title":"Live Attenuated Salmonella Enterica Serovar Choleraesuis Vaccine Vector Displaying Regulated Delayed Attenuation and Regulated Delayed Antigen Synthesis to Confer Protection against Streptococcus Suis in Mice","volume":"33","author":"Ji","year":"2015","journal-title":"Vaccine"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1637\/11094-041715-Reg","article-title":"Protection Against Necrotic Enteritis in Broiler Chickens by Regulated Delayed Lysis Salmonella Vaccines","volume":"59","author":"Jiang","year":"2015","journal-title":"Avian Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbiotec.2010.07.025","article-title":"Attenuation of Bacterial Virulence by Quorum Sensing-Regulated Lysis","volume":"150","author":"Silva","year":"2010","journal-title":"J. Biotechnol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/IAI.00444-10","article-title":"Salmonella Vaccine Vectors Displaying Delayed Antigen Synthesis in vivo to Enhance Immunogenicity","volume":"78","author":"Wang","year":"2010","journal-title":"Infect. Immun."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/1\/66\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:27:42Z","timestamp":1759919262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/1\/66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":166,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["vaccines13010066"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13010066","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}